Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/9/2025 | $175.00 → $200.00 | Market Perform | BMO Capital Markets |
| 4/23/2025 | $130.00 | Overweight → Neutral | Piper Sandler |
| 3/19/2025 | $167.00 | Equal-Weight | Stephens |
| 3/11/2025 | $205.00 → $175.00 | Market Perform | BMO Capital Markets |
| 3/3/2025 | Sell → Neutral | Monness Crespi & Hardt | |
| 1/17/2025 | $214.00 | Overweight | Cantor Fitzgerald |
| 12/20/2024 | $130.00 | Neutral → Sell | Monness Crespi & Hardt |
| 10/23/2024 | $165.00 | Sector Perform | RBC Capital Mkts |
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 4, 2025 /PRNewswire/ -- Equity Insider News Commentary – Generative AI is transforming healthcare faster than almost any other sector, according to a new McKinsey report. In a March survey of senior leaders across payers, providers, and healthcare services groups, 85% said they're actively using or exploring the technology. McKinsey's Global Institute estimates Gen AI could unlock $60–110 billion in annual value across pharma and medical products alone. With more AI pilot programs running than ever before, the tech world is racing to meet demand — including new efforts from Avant Technologies, Inc.
New vendor-agnostic interoperability advancements in Oracle Randomization and Trial Supply Management enable drug pooling and seamless supply management automation across multiple trials AUSTIN, Texas, June 4, 2025 /PRNewswire/ -- New interoperability advancements in Oracle's enterprise-grade Randomization and Trial Supply Management (RTSM) solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas. New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product. This aids in reducing inefficiencies an
Earnings Results to be released on June 11, 2025, After the Close of the Market AUSTIN, June 3, 2025 /PRNewswire/ -- Oracle Corporation today announced that its fourth quarter and fiscal year 2025 results will be released on Wednesday, June 11th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results. The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About Oracle Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.
SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi
Oracle is collaborating with Meharry Medical College regarding technology and resources for students and providers, a research collaborative, and a Meharry established community clinic and wellness center NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle Health and Meharry Medical College today announced plans to improve medical education and community healthcare across Middle Tennessee and beyond. As part of their non-binding MOU, Meharry and Oracle aim to establish a health technology education and research collaborative, a health innovation hub, and a community care and wellness center in Nashville. The two organizations will also work together to cultivate th
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
BMO Capital Markets reiterated coverage of Oracle with a rating of Market Perform and set a new price target of $200.00 from $175.00 previously
Piper Sandler downgraded Oracle from Overweight to Neutral and set a new price target of $130.00
Stephens initiated coverage of Oracle with a rating of Equal-Weight and set a new price target of $167.00
Earnings Results to be released on June 11, 2025, After the Close of the Market AUSTIN, June 3, 2025 /PRNewswire/ -- Oracle Corporation today announced that its fourth quarter and fiscal year 2025 results will be released on Wednesday, June 11th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results. The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About Oracle Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.
Mexican telecommunications operator reduces bill run times by 70% and achieves greater agility with Oracle Digital Business Experience on Oracle Cloud Infrastructure MEXICO CITY and AUSTIN, Texas, May 1, 2025 /PRNewswire/ -- Izzi, a subsidiary of Televisa Group, is modernizing its business support systems (BSS) in the cloud to bolster customer experience. By upgrading to the latest version of Oracle Communications Digital Business Experience running on Oracle Cloud Infrastructure (OCI), Izzi has reduced billing times by 70% and invoicing times by 60%, allowing the company to receive payments faster and improve cash flow. Izzi embarked on its modernization and cloud migration journey with su
Q3 Remaining Performance Obligations $130 billion, up 62% in USD & up 63% in constant currencyQ3 GAAP Earnings per Share up 20% to $1.02, Non-GAAP Earnings per Share up 4% to $1.47Q3 Total Revenue $14.1 billion, up 6% in USD and up 8% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $6.2 billion, up 23% in USD and up 25% in constant currencyQ3 Cloud Infrastructure (IaaS) Revenue $2.7 billion, up 49% in USD and up 51% in constant currencyQ3 Cloud Application (SaaS) Revenue $3.6 billion, up 9% in USD and up 10% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $0.9 billion, up 16% in USD and up 18% in constant currencyQ3 NetSuite Cloud ERP (SaaS) Revenue $0.9 billion, up 16% in USD a
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
SC 13G/A - ORACLE CORP (0001341439) (Subject)
SC 13G/A - ORACLE CORP (0001341439) (Subject)
SC 13G/A - ORACLE CORP (0001341439) (Subject)
SD - ORACLE CORP (0001341439) (Filer)
144 - ORACLE CORP (0001341439) (Subject)
144 - ORACLE CORP (0001341439) (Subject)